Education
About Us
Working with TipRanks
Follow Us
Coeptis Therapeutics Holdings (COEP)
NASDAQ:COEP
Total Valuation
Coeptis Therapeutics Holdings has a market cap or net worth of $75.68M. The enterprise value is $0.00.
Market Cap$75.68M
Enterprise Value$0.00
Share Statistics
Coeptis Therapeutics Holdings has 4,820,317 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding4,820,317
Owned by Insiders3.03%
Owned by Institutions―
Financial Efficiency
Coeptis Therapeutics Holdings’s return on equity (ROE) is -3.08 and return on invested capital (ROIC) is -161.24%.
Return on Equity (ROE)-3.08
Return on Assets (ROA)-1.10
Return on Invested Capital (ROIC)-161.24%
Return on Capital Employed (ROCE)-2.29
Revenue Per Employee0.00
Profits Per Employee-2.18M
Employee Count5
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Coeptis Therapeutics Holdings is ―. Coeptis Therapeutics Holdings’s PEG ratio is -0.00186.
PE Ratio―
PS Ratio0.00
PB Ratio3.32
Price to Fair Value3.32
Price to FCF-1.59
Price to Operating Cash Flow-7.19
PEG Ratio-0.00186
Income Statement
In the last 12 months, Coeptis Therapeutics Holdings had revenue of 0.00 and earned -9.81M in profits. Earnings per share was -5.65.
Revenue0.00
Gross Profit-1.04M
Operating Income-10.05M
Pretax Income-10.88M
Net Income-9.81M
EBITDA-9.44M
Earnings Per Share (EPS)-5.65
Cash Flow
In the last 12 months, operating cash flow was -8.09M and capital expenditures 0.00, giving a free cash flow of -8.09M billion.
Operating Cash Flow-8.09M
Free Cash Flow-8.09M
Free Cash Flow per Share-1.68
Dividends & Yields
Coeptis Therapeutics Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.11
52-Week Price Change286.82%
50-Day Moving Average13.87
200-Day Moving Average10.63
Relative Strength Index (RSI)51.44
Average Volume (3m)58.51K
Important Dates
Coeptis Therapeutics Holdings upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Coeptis Therapeutics Holdings as a current ratio of 0.23, with Debt / Equity ratio of 21.86%
Current Ratio0.23
Quick Ratio0.23
Debt to Market Cap0.13
Net Debt to EBITDA-0.09
Interest Coverage Ratio-25.38
Taxes
In the past 12 months, Coeptis Therapeutics Holdings has paid -1.06M in taxes.
Income Tax-1.06M
Effective Tax Rate0.10
Enterprise Valuation
Coeptis Therapeutics Holdings EV to EBITDA ratio is -1.21, with an EV/FCF ratio of -1.72.
EV to Sales0.00
EV to EBITDA-1.21
EV to Free Cash Flow-1.72
EV to Operating Cash Flow-1.72
Balance Sheet
Coeptis Therapeutics Holdings has $2.99M in cash and marketable securities with $1.33M in debt, giving a net cash position of $1.65M billion.
Cash & Marketable Securities$2.99M
Total Debt$1.33M
Net Cash$1.65M
Net Cash Per Share$0.34
Tangible Book Value Per Share$1.73
Margins
Gross margin is 31.67%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin31.67%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Coeptis Therapeutics Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―